Author

Antanas Gulbinas

Lithuanian University of Health SciencesORCID 0000-0002-6683-1339Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Denis M. GrantiD· 1 shared Fauzia Nurul IzzatiiD· 1 shared Hani Choksi· 1 shared Indrek TeinoiD· 1 shared Jason B. MatthewsiD· 1 shared Kristaps JaudzemsiD· 1 shared Landon J. EdgariD· 1 shared Linnea A. M. Erlingsson· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Denis M. GrantORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyFrontiers in ImmunologyPeer-reviewedJan 10, 2025

Loss of PARP7 increases type I interferon signalling and prevents pancreatic tumour growth by enhancing immune cell infiltration

Vinicius Kannen, Marit Rasmussen, Siddhartha Das…·Jason B. Matthews

This study shows that loss of PARP7 in pancreatic cancer cells increases type I interferon signaling and enhances immune cell infiltration, leading to reduced tumor growth.

5 citations

mousebulk RNA-seq

𝕏 PostBluesky